Master Alliance Provisions Guide (MAPGuide)

Public Health England, Model Fast Track Testing & Evaluation Agreement

  • Protecting & sharing information | Publication of results

Definitions

Global Stakeholders: (a) the United Nations or any of its specialized agencies (e.g. World Health Organization); (b) the Australia-Canada-UK-USA Medical Counter Measures Consortium; (c) the UK InterLab Forum; (d) the Australia-Canada-Germany-UK-USA BSL4Znet; (e) the Wellcome Trust; (f) the Bill and Melinda Gates Foundation; (g) organisations similar to those in (b) – (d) where the aim is to coordinate the activities and/or response to a global crisis facing people, animals and/or the environment (One Health); (h) organisations similar to those in (e) – (f) where the aim is to maintain a database of materials already tested against the Pathogens of Interest.

Publication: shall mean any scientific publication and/or communication including publishing any abstract, article or paper in a journal or an electronic repository, or make presentations at a conference or seminar,

9. Reports and publications

[…]

9.2 Notwithstanding clause 8, in the event that a party wishes to make a Publication regarding the Work (the Publishing Party), the Publishing Party shall submit to the other party a copy of the proposed Publication at least 30 days before the date of the proposed submission for Publication. The other party may, by giving a written notice to the Publishing Party (Notice) requiring the Publishing Party to amend the Publication to ensure compliance with clause 9.3 or delay the proposed Publication for a maximum of 3 month(s) after receipt of the Notice if, in the other Party’s reasonable opinion, that delay is necessary in order to seek patent or similar protection for any of the Results that are included in the Publication; or prevent the Publication of any of the other party’s Confidential Information. The other party must give the Notice within 15 days, which shall include the date of receipt of the Notice, after the other party receives details of the proposed Publication. If the Publishing Party does not receive a Notice within that period, the Publishing Party may proceed with the proposed Publication.

9.3 In any Publications, each party shall: ensure that the Institution contributors to the Work are named in the list of authors; and acknowledge the contribution of the other party.

[…]

9.6 For the avoidance of doubt, the parties agree that due to the seriousness of the current global crisis, it is important for the global scientific community to have access to information that indicates whether a given compound may be effective against the Pathogens of Interest. Accordingly the parties commit (in the case of the Institution, to the extent that it is free to do so) to either (i) publishing the Results even if the Material is inactive or poorly active in the relevant tests or animal models used in the Work, or (ii) allowing the Results to be available in databases set up by any of Global Stakeholders.

9.7 The provisions of this clause 9 shall survive termination of this agreement, however arising.